| Justin Mccarthy, M.d., P.a. | |
|
7202 Slide Rd Ste 100 Lubbock TX 79424-2555 | |
| (806) 761-0722 | |
| (806) 797-1265 |
| Full Name | Justin Mccarthy, M.d., P.a. |
|---|---|
| Speciality | Internal Medicine |
| Location | 7202 Slide Rd Ste 100, Lubbock, Texas |
| Authorized Official Name and Position | Justin H Mccarthy (MOPA) |
| Authorized Official Contact | 8067610722 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Justin Mccarthy, M.d., P.a. 7202 Slide Rd Ste 100 Lubbock TX 79424-2555 Ph: (806) 761-0722 | Justin Mccarthy, M.d., P.a. 7202 Slide Rd Ste 100 Lubbock TX 79424-2555 Ph: (806) 761-0722 |
| NPI Number | 1194732776 |
|---|---|
| Provider Enumeration Date | 08/03/2006 |
| Last Update Date | 12/13/2022 |
| Medicare PECOS PAC ID | 6103822978 |
|---|---|
| Medicare Enrollment ID | O20061018000598 |
News Archive
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery. Dr. Melinda Musgrave is determined to find out why.
Managing women with breast cancer who are breastfeeding is a complex issue. The Academy of Breastfeeding Medicine presents new recommendations in the peer-reviewed journal Breastfeeding Medicine.
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
The European Society for Integrative Medicine (ESIM), with support from Heel, announces a new international research prize in integrative medicine: the "Excellence in Integrative Medicine Research Award." Applicants are asked to submit papers by May 30, 2012.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194732776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | H7368 (Texas) | Primary |
| Provider Name | Justin H Mccarthy |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1730147315 PECOS PAC ID: 6406839091 Enrollment ID: I20040613000009 |
News Archive
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery. Dr. Melinda Musgrave is determined to find out why.
Managing women with breast cancer who are breastfeeding is a complex issue. The Academy of Breastfeeding Medicine presents new recommendations in the peer-reviewed journal Breastfeeding Medicine.
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
The European Society for Integrative Medicine (ESIM), with support from Heel, announces a new international research prize in integrative medicine: the "Excellence in Integrative Medicine Research Award." Applicants are asked to submit papers by May 30, 2012.
› Verified 9 days ago
| Provider Name | Virginia Lee Stinnett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982120531 PECOS PAC ID: 9739453929 Enrollment ID: I20170927001891 |
News Archive
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery. Dr. Melinda Musgrave is determined to find out why.
Managing women with breast cancer who are breastfeeding is a complex issue. The Academy of Breastfeeding Medicine presents new recommendations in the peer-reviewed journal Breastfeeding Medicine.
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
The European Society for Integrative Medicine (ESIM), with support from Heel, announces a new international research prize in integrative medicine: the "Excellence in Integrative Medicine Research Award." Applicants are asked to submit papers by May 30, 2012.
› Verified 9 days ago
News Archive
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery. Dr. Melinda Musgrave is determined to find out why.
Managing women with breast cancer who are breastfeeding is a complex issue. The Academy of Breastfeeding Medicine presents new recommendations in the peer-reviewed journal Breastfeeding Medicine.
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
The European Society for Integrative Medicine (ESIM), with support from Heel, announces a new international research prize in integrative medicine: the "Excellence in Integrative Medicine Research Award." Applicants are asked to submit papers by May 30, 2012.
› Verified 9 days ago
Caprock Medical Associates, P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3802 21st St, C, Lubbock, TX 79410 Phone: 806-791-5140 Fax: 806-791-0454 | |
Community Health Center Of Lubbock, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1318 Broadway, Lubbock, TX 79401 Phone: 806-765-2611 Fax: 806-767-0589 | |
Medical House Call Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10907 Quaker Ave, Lubbock, TX 79424 Phone: 806-771-7798 Fax: 806-687-9299 | |
Epiphany Medical Services Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13810 Quaker Ave, Lubbock, TX 79424 Phone: 806-576-3856 Fax: 806-305-3348 | |
Holly S. Stewart, Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3502 9th St, Suite 360, Lubbock, TX 79415 Phone: 806-744-7764 Fax: 806-744-7761 | |
Falcon Healthcare, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3223 S Loop 289 Ste 210, Corporate Office, Lubbock, TX 79423 Phone: 806-771-0995 Fax: 806-771-3813 | |
Ttuhsc - Dme Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3601 4th St, Ste 2a100, Lubbock, TX 79430 Phone: 806-743-2898 Fax: 806-743-2787 |